Ambev S A Income Statement Quarterly
ABEV
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Dec 31 2022)
IV. Quarter |
0
III. Quarter |
0
II. Quarter |
0
I. Quarter |
(Dec 31 2021)
IV. Quarter |
| Revenue From Contracts With Customers |
|
- |
- |
- |
|
| Revenue |
|
- |
- |
- |
|
| Cost Of Sales |
|
- |
- |
- |
|
| Other Revenue |
|
- |
- |
- |
|
| Total Revenue |
15,144.67 |
0.00 |
0.00 |
0.00 |
13,842.32 |
| Cost Of Sales |
7,680.20 |
- |
- |
- |
6,775.34 |
| Gross
Profit |
7,464.47 |
0.00 |
0.00 |
0.00 |
7,066.97 |
| Selling, Administration, Marketing |
994.99 |
- |
- |
- |
926.71 |
| Depriciation & Amortization |
- |
- |
- |
- |
- |
| Research & development |
- |
- |
- |
- |
- |
| Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
| OtherOperating Income Expense |
3,108.80 |
- |
- |
- |
-1,434.86 |
| Unusual Expense /-Income |
- |
- |
- |
- |
- |
| Total operating costs including COS |
11,783.99 |
- |
- |
- |
10,597.06 |
| Operating income/-loss
|
3,360.68 |
- |
- |
- |
3,245.26 |
|
Other Deductions / - Income |
| Interest expense |
- |
- |
- |
- |
- |
| Interest income |
- |
- |
- |
- |
- |
| Net interest expense/-income |
- |
- |
- |
- |
- |
| Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
| Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
| Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
| Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
| Other loss/ -income |
-187.68 |
- |
- |
- |
230.74 |
| Total costs & expenses |
12,439.91 |
0.00 |
0.00 |
0.00 |
11,228.07 |
| Income /-loss before income taxes |
2,704.76 |
0.00 |
0.00 |
0.00 |
2,614.25 |
| Income taxes expenses/-benefit |
-124.56 |
- |
- |
- |
120.95 |
| Income after income taxes |
2,829.33 |
0.00 |
0.00 |
0.00 |
2,493.29 |
| Net income/-loss
of other equity |
- |
- |
- |
- |
- |
| Income/-loss
from cont. Ops. |
2,829.33 |
0.00 |
0.00 |
0.00 |
2,493.29 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
2,829.33 |
0.00 |
0.00 |
0.00 |
2,493.29 |
| Noncontrolling interests |
82.33 |
- |
- |
- |
85.80 |
| Prefered dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
- |
- |
- |
| Income/-loss to shareholder |
2,747.00 |
0.00 |
0.00 |
0.00 |
2,407.49 |
| EBIT |
0.00 |
0.00 |
0.00 |
0.00 |
2,614.25 |
| EBITD |
0.00 |
0.00 |
0.00 |
0.00 |
3,639.62 |
| EBITDA |
0.00 |
0.00 |
0.00 |
0.00 |
3,639.62 |
| Per
Share (GAAP Quarterly, in $) |
(Dec 31 2022)
IV. Quarter |
0
III. Quarter |
0
II. Quarter |
0
I. Quarter |
(Dec 31 2021)
IV. Quarter |
| Basic EPS (excl. extra
items) |
0.17 |
0.00 |
0.00 |
0.00 |
0.15 |
| Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic Net EPS |
0.17 |
0.00 |
0.00 |
0.00 |
0.15 |
| Basic shares outstanding (Mill.
of Units) |
15,847.75 |
0.00 |
0.00 |
0.00 |
15,736.46 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
0.17 |
0.00 |
0.00 |
0.00 |
0.15 |
| Diluted average shares (Mill.
of Units) |
15,847.75 |
15,847.75 |
15,847.75 |
15,847.75 |
15,856.59 |
| Dividend per share |
- |
- |
- |
- |
- |
|
|
